428 related articles for article (PubMed ID: 11279155)
21. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
Soltoff SP
J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
[TBL] [Abstract][Full Text] [Related]
22. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
Gamett DC; Greene T; Wagreich AR; Kim HH; Koland JG; Cerione RA
J Biol Chem; 1995 Aug; 270(32):19022-7. PubMed ID: 7642563
[TBL] [Abstract][Full Text] [Related]
23. Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells.
Ewald JA; Wilkinson JC; Guyer CA; Staros JV
Exp Cell Res; 2003 Jan; 282(2):121-31. PubMed ID: 12531698
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.
Xia W; Mullin RJ; Keith BR; Liu LH; Ma H; Rusnak DW; Owens G; Alligood KJ; Spector NL
Oncogene; 2002 Sep; 21(41):6255-63. PubMed ID: 12214266
[TBL] [Abstract][Full Text] [Related]
26. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
Deb TB; Wong L; Salomon DS; Zhou G; Dixon JE; Gutkind JS; Thompson SA; Johnson GR
J Biol Chem; 1998 Jul; 273(27):16643-6. PubMed ID: 9642214
[TBL] [Abstract][Full Text] [Related]
27. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
Samanta A; Qian X; Greene MI
DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
[TBL] [Abstract][Full Text] [Related]
28. EGF activates ErbB-2 and stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells.
Krymskaya VP; Hoffman R; Eszterhas A; Kane S; Ciocca V; Panettieri RA
Am J Physiol; 1999 Feb; 276(2):L246-55. PubMed ID: 9950886
[TBL] [Abstract][Full Text] [Related]
29. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
Decker SJ
J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
[TBL] [Abstract][Full Text] [Related]
30. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
31. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
Graus-Porta D; Beerli RR; Hynes NE
Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
33. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
34. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.
Dowlati A; Nethery D; Kern JA
Mol Cancer Ther; 2004 Apr; 3(4):459-63. PubMed ID: 15078989
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
36. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo.
Ezeh PI; Farbman AI
J Neurobiol; 1998 Nov; 37(2):199-210. PubMed ID: 9805267
[TBL] [Abstract][Full Text] [Related]
37. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
38. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
[TBL] [Abstract][Full Text] [Related]
39. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
40. Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis.
Jones JT; Ballinger MD; Pisacane PI; Lofgren JA; Fitzpatrick VD; Fairbrother WJ; Wells JA; Sliwkowski MX
J Biol Chem; 1998 May; 273(19):11667-74. PubMed ID: 9565587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
